These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 7527999
1. Analogues of peptide 9-21 of glycoprotein D of herpes simplex virus and their binding to group VII monoclonal antibodies. Welling-Wester S, Feijlbrief M, Koedijk DG, Drijfhout JW, Weijer WJ, Scheffer AJ, Welling GW. Arch Virol; 1994; 138(3-4):331-40. PubMed ID: 7527999 [Abstract] [Full Text] [Related]
2. Immunological properties of multiple repeats of a linear epitope of herpes simplex virus type 1 glycoprotein D. Van der Ploeg JR, Drijfhout JW, Feijlbrief M, Bloemhoff W, Welling GW, Welling-Wester S. J Immunol Methods; 1989 Nov 30; 124(2):211-7. PubMed ID: 2480978 [Abstract] [Full Text] [Related]
3. Kinetic analysis of synthetic analogues of linear-epitope peptides of glycoprotein D of herpes simplex virus type 1 by surface plasmon resonance. Lasonder E, Schellekens GA, Koedijk DG, Damhof RA, Welling-Wester S, Feijlbrief M, Scheffer AJ, Welling GW. Eur J Biochem; 1996 Aug 15; 240(1):209-14. PubMed ID: 8797855 [Abstract] [Full Text] [Related]
4. Structural properties and reactivity of N-terminal synthetic peptides of herpes simplex virus type 1 glycoprotein D by using antipeptide antibodies and group VII monoclonal antibodies. Bosch DL, Geerligs HJ, Weijer WJ, Feijlbrief M, Welling GW, Welling-Wester S. J Virol; 1987 Nov 15; 61(11):3607-11. PubMed ID: 2444718 [Abstract] [Full Text] [Related]
5. Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting. Cohen GH, Isola VJ, Kuhns J, Berman PW, Eisenberg RJ. J Virol; 1986 Oct 15; 60(1):157-66. PubMed ID: 2427745 [Abstract] [Full Text] [Related]
6. Epitopes of herpes simplex virus type 1 glycoprotein B that bind type-common neutralizing antibodies elicit type-specific antibody-dependent cellular cytotoxicity. Sanchez-Pescador L, Paz P, Navarro D, Pereira L, Kohl S. J Infect Dis; 1992 Sep 15; 166(3):623-7. PubMed ID: 1380051 [Abstract] [Full Text] [Related]
7. Intratypic variation of herpes simplex virus type 2 isolates detected by monoclonal antibodies against viral glycoproteins. Bhattarakosol P, Yoosook C, Cross A. Arch Virol; 1990 Sep 15; 115(1-2):89-100. PubMed ID: 1701081 [Abstract] [Full Text] [Related]
8. Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins. Babas T, Le Grand R, Dormont D, Bahraoui E. AIDS Res Hum Retroviruses; 1997 Sep 01; 13(13):1109-19. PubMed ID: 9282816 [Abstract] [Full Text] [Related]
9. Fine mapping of antigenic site II of herpes simplex virus glycoprotein D. Isola VJ, Eisenberg RJ, Siebert GR, Heilman CJ, Wilcox WC, Cohen GH. J Virol; 1989 May 01; 63(5):2325-34. PubMed ID: 2467994 [Abstract] [Full Text] [Related]
10. Synthesis and comparison of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII. Mezö G, de Oliveira E, Krikorian D, Feijlbrief M, Jakab A, Tsikaris V, Sakarellos C, Welling-Wester S, Andreu D, Hudecz F. Bioconjug Chem; 2003 May 01; 14(6):1260-9. PubMed ID: 14624643 [Abstract] [Full Text] [Related]
11. Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function. Cairns TM, Shaner MS, Zuo Y, Ponce-de-Leon M, Baribaud I, Eisenberg RJ, Cohen GH, Whitbeck JC. J Virol; 2006 Mar 01; 80(6):2596-608. PubMed ID: 16501070 [Abstract] [Full Text] [Related]
13. An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain. Wolinsky JS, Sukholutsky E, Moore WT, Lovett A, McCarthy M, Adame B. J Virol; 1993 Feb 01; 67(2):961-8. PubMed ID: 7678312 [Abstract] [Full Text] [Related]
15. Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. Liljeqvist JA, Trybala E, Svennerholm B, Jeansson S, Sjögren-Jansson E, Bergström T. J Gen Virol; 1998 May 01; 79 ( Pt 5)():1215-24. PubMed ID: 9603337 [Abstract] [Full Text] [Related]
16. Identification of the core residues of the epitope of a monoclonal antibody raised against glycoprotein D of herpes simplex virus type 1 by screening of a random peptide library. Schellekens GA, Lasonder E, Feijlbrief M, Koedijk DG, Drijfhout JW, Scheffer AJ, Welling-Wester S, Welling GW. Eur J Immunol; 1994 Dec 01; 24(12):3188-93. PubMed ID: 7805747 [Abstract] [Full Text] [Related]
17. Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity. Däumer MP, Schneider B, Giesen DM, Aziz S, Kaiser R, Kupfer B, Schneweis KE, Schneider-Mergener J, Reineke U, Matz B, Eis-Hübinger AM. Med Microbiol Immunol; 2011 May 01; 200(2):85-97. PubMed ID: 20931340 [Abstract] [Full Text] [Related]
18. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Roehrig JT, Bolin RA, Kelly RG. Virology; 1998 Jul 05; 246(2):317-28. PubMed ID: 9657950 [Abstract] [Full Text] [Related]
19. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1. Wang K, Tomaras GD, Jegaskanda S, Moody MA, Liao HX, Goodman KN, Berman PW, Rerks-Ngarm S, Pitisuttithum P, Nitayapan S, Kaewkungwal J, Haynes BF, Cohen JI. J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28701403 [Abstract] [Full Text] [Related]